BTG Competitors and Similar CompaniesClear all
BTG's competitors and similar companies include Zogenix, NIOX, Durect and Paion.
 Zogenix Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology. |  NIOX NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies |  Durect DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases. |  Paion PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs. | ||
Founding Date | Founding Date 1948 | Founding Date 2006 | Founding Date 2006 | Founding Date N/A | Founding Date 2000 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public | Type Public |
Tags | |||||
Locations | Locations Emeryville, US HQ Maidenhead, GB | Locations Morrisville, US HQ Bad Homburg Vor Der Höhe, DE Uppsala, SE Morrisville, US | Locations Cupertino, US HQ | Locations Aachen, DE HQ Odense, DK Hoofddorp, NL Richmond, GB | |
Employees | Employees 650 | Employees 743% increase | Employees 91 | Employees 902% increase | Employees 3218% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 340.9 m | Valuation ($) 45.3 m | Valuation ($) 49.7 m |
Financial | |||||
Revenue (est.) | Revenue (est.) £731.3m (FY, 2019) | Revenue (est.) $81.7m (FY, 2021) | Revenue (est.) £48.7m (FY, 2025) | Revenue (est.) $2m (FY, 2024) | Revenue (est.) €33.2m (FY, 2022) |
Cost of goods | Cost of goods £221m (FY, 2019) | Cost of goods $4.8m (FY, 2021) | Cost of goods £11.1m (FY, 2025) | Cost of goods $78k (FY, 2024) | Cost of goods €382k (FY, 2022) |
Gross profit | Gross profit £510.3m (FY, 2019) | Gross profit N/A | Gross profit £38.2m (FY, 2025) | Gross profit $2m (FY, 2024) | Gross profit €33.4m (FY, 2022) |
Net income | Net income £88.3m (FY, 2019) | Net income ($227.4m) (FY, 2021) | Net income £7m (FY, 2025) | Net income ($8.3m) (FY, 2024) | Net income (€579k) (FY, 2022) |
Funding | |||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 122.8m | Total funding raised $ 20m | Total funding raised $ 15.2m |
For sources of this data, please see the company profile
View Company Profiles
Zogenix
HQ
Emeryville, US
Specialty pharmaceutical developing CNS and pain therapies and featuring DosePro needle free delivery technology.
View companyNIOX
HQ
Morrisville, US
Employees
91
NIOX (formerly Circassia) is a specialty biopharmaceutical company focused on developing novel immunotherapies
View companyDurect
HQ
Cupertino, US
Employees
90↑ 2% increase
DURECT is a specialty pharmaceutical company developing innovative drugs for pain and chronic diseases.
View companyPaion
HQ
Aachen, DE
Employees
32↓ 18% decrease
PAION is a biopharmaceutical company developing and commercializing drug candidates for diseases with substantial unmet medical needs.
View company